Abingdon Health shares to begin trading on US OTCQB market from 21 April

Abingdon Health PLC (AIM:ABDX), the York-based developer and manufacturer of rapid diagnostic tests, will begin trading on the OTCQB Venture Market in the United States under the ticker ABDXF from 21 April 2026. The move follows the company's September 2025 announcement of a second phase of expansion at its Madison, Wisconsin facility, funded by a capital raise completed in October 2025.